Stay updated on AK104 in First-line Treatment of G/GEJ AdenoCa Clinical Trial
Sign up to get notified when there's something new on the AK104 in First-line Treatment of G/GEJ AdenoCa Clinical Trial page.

Latest updates to the AK104 in First-line Treatment of G/GEJ AdenoCa Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedA new revision v3.3.4 was added to the history and the previous revision v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check41 days agoChange DetectedA new revision entry (v3.3.3) was added and older items ('HHS Vulnerability Disclosure' and 'Revision: v3.3.2') were removed.SummaryDifference0.2%

- Check70 days agoChange DetectedStudy Status and Recruitment Status were updated to show the trial is Completed, replacing the previous 'Active, not recruiting' status.SummaryDifference0.8%

- Check77 days agoChange DetectedThe notice about government funding and operating status at the top of the page has been removed. This change does not affect the study data or record availability. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check99 days agoChange DetectedThe new screenshot shows updates to the Study Status and Recruitment Status in the record history. These changes reflect the trial's current activity and enrollment status.SummaryDifference0.1%

- Check120 days agoChange DetectedMajor changes: updated operating status notice and version to v3.2.0; removal of v3.1.0.SummaryDifference13%

Stay in the know with updates to AK104 in First-line Treatment of G/GEJ AdenoCa Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK104 in First-line Treatment of G/GEJ AdenoCa Clinical Trial page.